‌

People currently taking valproic acid/sodium valproate for epilepsy, bipolar disorder, or migraine prevention. Patients starting treatment, changing doses, or not responding well to therapy. Anyone on valproate with side effects, suspected toxicity, or requiring routine monitoring.